Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 12;48(1):91-103.
doi: 10.1093/jpepsy/jsac068.

Internalizing Symptoms in Adolescents With Sickle Cell Disease

Affiliations

Internalizing Symptoms in Adolescents With Sickle Cell Disease

Andrew M Heitzer et al. J Pediatr Psychol. .

Abstract

Objective: Sickle cell disease (SCD) is a genetic blood disorder that may affect patients' mood and behavior. However, measuring the prevalence of internalizing symptoms (anxiety and depression) in patients with SCD has been elusive. We assessed internalizing symptoms in adolescents with SCD to evaluate prevalence and to test whether neurocognitive performance and frequency of pain-related episodes were associated with internalizing concerns.

Methods: One hundred eighty-five patients (57% HbSS/HbSß0-thalassemia, 43% HbSC/HbSß+-thalassemia), ages 12-18 years, received a neuropsychological evaluation as a part of a larger cohort study. Internalizing symptoms were measured using the Behavior Assessment System for Children, Second or Third Edition. Scores on the depression and anxiety scales were compared to normative values using Wilcoxon signed rank test. Spearman correlations examined associations between neurocognitive performances and internalizing symptoms. Robust multivariable regression models measured associations between internalizing symptoms and age, sex, sickle genotype, total hemoglobin, fetal hemoglobin, socioeconomic status, and frequency of pain episodes.

Results: Parent- and self-reported ratings of internalizing symptoms were not elevated compared to normative expectations. Overall, 1.8% and 6.3% of the sample displayed clinically elevated symptoms of anxiety and depression based on self-report, respectively. There were no associations between internalizing symptoms and neurocognitive performance (all p > .05). In multivariable analyses, the frequency of pain episodes was positively associated with self-reported anxiety (p = .006) and parent-reported depressive symptoms (p = .017).

Conclusions: Adolescents with SCD do not report elevated internalizing symptoms compared to normative expectations. Further research is needed to examine the trajectory of internalizing symptoms and the bidirectional relationship between pain and psychosocial functioning in SCD.

Keywords: anemia; anxiety; depression; neurocognitive; pain; sickle cell disease; somatic.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Histograms of internalizing symptom scores. Internalizing symptom scores based on the Anxiety and Depression scales from the Behavior Assessment System for Children, Second or Third Edition. Higher scores are indicative of greater symptoms. Gender-based normative data were used for all participants. T scores have a mean of 50 and SD of 10.

Similar articles

Cited by

References

    1. Achenbach T. M., Edelbrock C. S. (1981). Behavioral problems and competencies reported by parents of normal and disturbed children aged four through sixteen. Monographs of the Society for Research in Child Development, 46(1), 1–82. - PubMed
    1. Achenbach T. M., McConaughy S. H., Howell C. T. (1987). Child/adolescent behavioral and emotional problems: Implications of cross-informant correlations for situational specificity. Psychological Bulletin, 101(2), 213–232. 10.1037/0033-2909.101.2.213 - DOI - PubMed
    1. Adam S. S., Flahiff C. M., Kamble S., Telen M. J., Reed S. D., De Castro L. M. (2017). Depression, quality of life, and medical resource utilization in sickle cell disease. Blood Advances, 1(23), 1983–1992. 10.1182/bloodadvances.2017006940 - DOI - PMC - PubMed
    1. Anie K. A., Green J. (2015). Psychological therapies for sickle cell disease and pain. Cochrane Database of Systematic Reviews, (5), 1–28. - PMC - PubMed
    1. Badawy S. M., Thompson A. A., Lai J.-S., Penedo F. J., Rychlik K., Liem R. I. (2017). Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease. Pediatric Blood & Cancer, 64(6), e26369. 10.1002/pbc.26369 - DOI - PubMed

Publication types

Substances